{"id": "1355523332901384193", "creation": 1612016921.0, "user_id": "1321134820894846976", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Novavax, Inc. #NASDAQ: $NVAX shares closed Friday up 65% to $220.94 following the release of interim data from its Phase 3 UK trial of its #COVID19 #vaccine. Further upward price movement was also seen as investors compared its efficacy to data of $JNJ", "first_save": 1634559108.199414, "hashtags": ["#NASDAQ", "#COVID19", "#VACCINE"]}